Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: 3i execs buy the dip, AstraZeneca CFO offloads shares

(Sharecast News) - London-listed companies 3i Group and AstraZeneca disclosed fresh director dealings on Wednesday, with senior executives at the private equity group adding to their holdings while AstraZeneca's finance chief sold American Depositary Shares. 3i Group said chief executive Simon Borrows purchased 30,000 shares at 3,366.7p each on the London Stock Exchange on 13 November.

Peter Wirtz, another senior manager, bought 25,000 shares at 3,415.53p on the same day.

A further transaction was reported on 14 November, when Karen McKellar, the wife of director Peter McKellar, acquired 4,000 shares at 3,344.6736p.

All three purchases were notified to the company this week.

The transactions followed a sharp fall in 3i's share price on Wednesday, when the stock slid 11.4% to 3,606p after the FTSE 100 group flagged a tougher investment environment despite reporting a stronger second quarter.

Borrows said at the time that the private equity portfolio had "maintained good momentum" but warned that the transaction market and wider backdrop would remain challenging into the second half of the financial year.

The update highlighted continued strong growth at discount retailer Action, which drove a 13% total return and lifted net asset value to 2,857p per share.

AstraZeneca meanwhile reported that chief financial officer Aradhana Sarin sold 15,000 American Depositary Shares on 12 November at a price equivalent to $88.6345 per ordinary share.

The sale was executed on the Nasdaq, and disclosed to the company a day later.

Two ADSs represent one AstraZeneca share.

It came as AstraZeneca's shares traded near record highs, buoyed by stronger-than-expected quarterly earnings and a US drug-pricing agreement reached in October.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Resolute Mining Limited Npv (di) (RSG) Director name: Parker ,Adrienne Amount purchased: 5,263 @ $4,894.59 Value: $21,242,043.66

London Btc Company Limited Npv (di) (BTC) Director name: Lenigas,David Amount purchased: 1,000,000 @ 350.00p Value: £3,500,000.00

3i Group (III) Director name: Borrows,Simon Amount purchased: 30,000 @ 3,366.70p Value: £1,010,009.99

Wpp (WPP) Director name: Rose ,Cindy Amount purchased: 50,000 @ 288.70p Value: £144,350.00

Wpp (WPP) Director name: Jansen ,Philip Amount purchased: 50,000 @ 285.10p Value: £142,550.00

Asiamet Resources Limited (di) (ARS) Director name: Djauhari,Eva Armila Amount purchased: 7,911,115 @ 1.50p Value: £118,666.72

Smiths News (SNWS) Director name: Malhotra,Manju Amount purchased: 30,006 @ 66.30p Value: £19,893.98

Experian (EXPN) Director name: DeRose,Kathleen Amount purchased: 250 @ $44.53 Value: $9,179.93

Xp Factory (XPF) Director name: Bird,Graham Amount purchased: 1,327 @ 11.30p Value: £149.95

Xp Factory (XPF) Director name: Harpham,Richard Amount purchased: 1,327 @ 11.30p Value: £149.95

Top Director Sells

Astrazeneca (AZN) Director name: Sarin,Aradhana Amount sold: 15,000 @ $88.63 Value: $1,096,328.42

Share this article

Related Sharecast Articles

Director dealings: Bango CFO makes share purchase
(Sharecast News) - Bango revealed on Wednesday that chief financial officer Matt Wilson had acquired 12,755 ordinary shares in the AIM-listed digital vending machine operator.
Director dealings: Insig AI CEO snaps up shares
(Sharecast News) - InsigAI revealed on Tuesday that chief executive Richard Bernstein had acquired 134,120 ordinary shares in the AIM-listed data science and machine learning solutions company.
Director dealings: Duke Capital CIO raises stake
(Sharecast News) - Duke Capital revealed on Monday that chief investment officer Charles Cannon-Brookes had acquired 811,779 ordinary shares in the AIM-listed royalty investor.
Director dealings: MP Evans CEO sells shares
(Sharecast News) - MP Evans revealed on Friday that chief executive Matthew Coulson had disposed of 8,450 ordinary shares in the AIM-listed palm oil producer.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.